Glucocorticoid-suppressible hyperaldosteronism: an update. 1990

A Ganguly
Department of Medicine, University of South Florida, College of Medicine, Tampa.

UI MeSH Term Description Entries
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006929 Hyperaldosteronism A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA. Aldosteronism,Conn Syndrome,Conn's Syndrome,Primary Hyperaldosteronism,Conns Syndrome,Hyperaldosteronism, Primary,Syndrome, Conn,Syndrome, Conn's

Related Publications

A Ganguly
April 1992, Lancet (London, England),
A Ganguly
January 1987, Zhonghua nei ke za zhi,
A Ganguly
January 1991, The American journal of medicine,
A Ganguly
December 1989, Endocrinologia japonica,
A Ganguly
February 1993, Journal of molecular endocrinology,
A Ganguly
January 1987, The Journal of clinical endocrinology and metabolism,
A Ganguly
October 1981, The New England journal of medicine,
A Ganguly
June 1996, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!